THE SURGICAL CARE IMPROVEMENT PROJECT (SCIP) was established in 2006 with the goal of reducing surgical complications by 25% in 2010. Of the 9 performance measures, 6 are related to surgical site infection prevention. Efforts to reduce surgical site infection are important because this complication results in significant morbidity and additional resource use. To this end, the SCIP was designed to improve adherence for prophylactic antibiotic administration, as well as processes related to glucose control, hair removal from the surgical site, and intraoperative normothermia, in patients undergoing elective surgical procedures. It has achieved this goal to the extent that hospitals have successfully implemented these processes. However, what evidence exists demonstrating that improved adherence has achieved the goal of reducing surgical complications? Complications from surgical procedures are costly and cause substantial patient morbidity. Patients need transparent information guiding them to the best hospitals for their surgical procedure and third-party payers need a mechanism to influence and make accountable the care of patients undergoing expensive procedures. The time, resources, and importance placed on SCIP process measures lead to the conclusion that adherence to these measures can discriminate practices associated with optimal surgical outcomes. The SCIP measures were added to the Hospital Compare Web site (http://www.hospitalcompare .hhs.gov) with the goal of guiding patients about where to receive surgical care, based on the underlying assumption that higher performance on these measures equals better surgical outcomes. Furthermore, the Centers for Medicare & Medicaid Services has proposed use of the SCIP measures for value-based purchasing and payment to hospitals. The report by Stulberg et al in this issue of JAMA is the largest study to date that fails to demonstrate an association between adherence to SCIP process measures and the occurrence of postoperative infections. The authors found no significant association between individual process measures or the all-or-none composite core measurement composed of all 3 measures for prophylactic antibiotic administration and postoperative infection. They report a modest association between adherence to a composite measure that included at least 2 of the 6 SCIP measures applied to an expanded SCIP population and postoperative infection. Despite substantial improvements in SCIP adherence over the 2-year study period, postoperative infection rates actually increased. The SCIP includes 3 core infection-prevention measures: SCIP-1, antibiotic administration within 60 minutes prior to incision; SCIP-2, appropriate selection of antibiotic coverage; and SCIP-3, timely discontinuation of antibiotics. The SCIP-2 measure ensures that adequate antimicrobial coverage is administered with a focus on limiting too broad of coverage. Similarly, for the SCIP-3 measure, data support that prolonged coverage has no incremental improvement in surgical site infection rates and is potentially harmful due to the development of resistant organisms. Of these 3 measures, there has been evidence to support that the SCIP-1 measure reduces the incidence of surgical site infection, although that evidence involves whether the prophylactic antibiotic is administered at all, and not the timing of antibiotic administration. Other studies have shown that even though administration of antibiotics in the operating room resulted in better SCIP-1 adherence, there was no association with lower surgical site infection in patientor hospital-level analyses. Delivery of preoperative prophylactic antibiotics improves surgical site infection rates in the appropriate clinical setting and all patients in the study by Stulberg et al received prophylactic antibiotics. However, the SCIP-1 measures a dichotomous variable based on a continuous event (the time between antibiotic administration and surgical incision). This measure presumes that any antibiotic administered within 60 minutes prior to incision is effective, but that antibiotics administered outside that interval are not. To date, no prospective trials have validated the 60-minute window as a measure to discriminate meaningful differences in patient outcomes. Between 2002 and 2009, at least 8 reports that evaluated the association between SCIP-1 adherence and surgical site infection
Read full abstract